Overview

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Status:
Unknown status

Trial end date:
2016-12-01

Target enrollment:
0

Participant gender:
All

Summary

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Phoenix Children's Hospital

Treatments:

Mandelic Acids
Oxybutynin
Tamsulosin

Criteria

Inclusion Criteria:

- Patients aged 4-18 years will be enrolled in this study. We will include all patients
who will have a ureteral stent placement after their procedure.

Exclusion Criteria:

- Patients with developmental delay or unable to verbalize their pain level will be
excluded.